Personalized v. Standard Care
Why do Pharma companies care about personalized medicine given that this might limit the population for which their drug is approved?
Low response rates to therapy and lack of patient benefit compared to the standard of care can put success of a clinical trial and overall drug development at risk. Therefore pharma companies are invested in diagnostic programs to:
- select the right patients for their drug
- minimize the risk of drug failure
- get drugs to market faster